Ketamine
What are the Concerns With Self-Administering Psychedelics?: Mindshifting Moments #12
Host Margaret Williamson is back with another mind-altering topic as part of our Mindshifting Moments segment. What will you learn this time? Well, it’s…
Host Margaret Williamson is back with another mind-altering topic as part of our Mindshifting Moments segment. What will you learn this time? Well, it’s time to talk about the self-administration of psychedelics in today’s world.
What does it mean to self-administer psychedelics? What are the consequences?
Find out more as Margaret welcomes Warren Gumpel of KetaMD.
Meet Warren Gumpel
In this episode of Mindshifting Moments, the Co-Founder of KetaMD, Warren Gumpel joins Margaret Williamson.
As a leading expert in the ketamine space, Warren has spent the last five years working as an operator, consultant, marketer, and advocate. Warren has guided existing ketamine clinics, IV clinics, and rehab centers across the U.S. to integrate best practices to enhance their existing businesses and ketamine practices. Along with co-founder Zappy Zapolin, Warren created KetaMD to bring at-home medical ketamine to the masses.
Transcription
The transcription will be available after the event.
-
Law & Regulation1 week ago
Relmada Therapeutics trims losses, slashes research costs
-
Psychedelics1 week ago
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
-
Psychedelics1 week ago
Numinus Wellness Submits Clinical Trial Application
-
Psychedelics1 week ago
Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin
-
Psychedelics1 week ago
MindBio Therapeutics Corp. Begins Phase 2B Take-Home Microdosing Clinical Trial in Patients with Major Depressive Disorder
-
Psilocybin1 week ago
Indigenous Psilocybin Practices Around the World
-
Psychedelics1 week ago
Psilocybin Study Reveals the Brain Suppresses Reactions To Angry Faces
-
Psychedelics1 week ago
Gilgamesh Receives Grant To Combat Opioid Dependency